This HSJ Podcast explores the changing relationship between the life sciences industry and the NHS. Forged by the covid crisis, protocols have been set aside and companies have worked with regulatory bodies to accelerate clinical trials and deliver equipment to the NHS front line. The panel reflects on events of the past few months and looks towards the future and with hope of a new style of working together.

HSJ editor Alastair McLellan talks to Hugo Breda, UK & Ireland Managing Director of Johnson & Johnson, Dr Rav Seeruthun, Medical Director, Roche UK, and Chris Hopson, Chief Executive at NHS Providers, about the accelerated pace of change across industry and the NHS. They’ll share insights on:

· how previously transactional relationships are evolving into value-based partnerships, based on greater levels of openness and transparency

· the potential to continue the speed and adoption of innovation

· working together to support the reduction in the backlog of elective waiting lists

· where they see the real opportunities for the future